Recurrence after successful treatment of pulmonary tuberculosis (TB) with multidrug-resistance (MDR)

A. Skrahina, A. Astrauko, H. Hurevich, A. Skrahin (Minsk, Belarus)

Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Session: The challenge of multidrug-resistant tuberculosis
Session type: Thematic Poster Session
Number: 2496
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Skrahina, A. Astrauko, H. Hurevich, A. Skrahin (Minsk, Belarus). Recurrence after successful treatment of pulmonary tuberculosis (TB) with multidrug-resistance (MDR). Eur Respir J 2008; 32: Suppl. 52, 2496

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Surgical treatment of destructive pulmonary tuberculosis (TB) with multi-drug resistance (MDR)
Source: Eur Respir J 2004; 24: Suppl. 48, 723s
Year: 2004

Surgical treatment of multidrug resistant pulmonary tuberculosis (MDR-TB)
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009


Treatment results of multidrug resistant pulmonary tuberculosis (MDR-TB)
Source: Eur Respir J 2005; 26: Suppl. 49, 199s
Year: 2005

Surgical treatment of multidrug-resistant tuberculosis (MDR TB)
Source: Eur Respir J 2003; 22: Suppl. 45, 523s
Year: 2003

Artificial pneumothorax in the treatment of multi drug resistant tuberculosis (MDR TB)
Source: Eur Respir J 2006; 28: Suppl. 50, 586s
Year: 2006

Treatment of multidrug resistant pulmonary tuberculosis (MDR-TB) with different pattern of resistance
Source: Eur Respir J 2004; 24: Suppl. 48, 723s
Year: 2004

Primary multidrug resistance (PMDR) of mycobacterium tuberculosis (MBT) to antimycobacterial drugs (AMBTD) in the patients with destructive TB.
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008

Multidrug resistant tuberculosis (MDR – TB) treatment outcomes in Iran
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004

Our experience in multi drug resistant tuberculosis (MDR TB) treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005

Bio-Chip (BCh) technology for diagnostics of multidrug resistance (DR) of mycobacterium tuberculosis (MBT) from patients with disseminated tuberculosis (DT)
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008


Primary resistance (PR) of mycobacterium tuberculosis (MBT) to antimicrobial drugs (AMBD) in patients (P) with destructive pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 655s
Year: 2004

Short course of chemotherapy of multidrug resistant tuberculosis (MDR TB)
Source: Eur Respir J 2004; 24: Suppl. 48, 722s
Year: 2004

Comparative analysis between multidrug resistant tuberculosis (MDR-TB) and extensively drug resistant tuberculosis (XDR-TB) in HIV(+) patients
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009


New era of artificial pneumothorax in the management of multidrug resistant (MDR) pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 556s
Year: 2003

Efficacy and safety of linezolid for the treatment of multidrug resistant tuberculosis (MDR-TB) and disease by non tuberculous mycobacteria (NTM)
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011

Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: epidemiology, diagnosis and treatment
Source: Annual Congress 2008 - Infection year in review
Year: 2008


A multicentric cohort analysis of culture conversion and reversion in multidrug resistant tuberculosis (MDRTB) patients
Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights
Year: 2013

Peculiarities and results of treatment in XDR pulmonary tuberculosis (PTB)
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012

Treatment possibilities of multi-drug resistant (MDR) tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 525s
Year: 2003

Extensively drug-resistant (XDR) pulmonary tuberculosis in HIV negative cases
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008